To investigate the potential clinical role of PICH in breast cancer, we collected breast cancer and the matched adjacent normal tissue samples from 194 human subjects and performed IHC using an anti-PICH antibody, the specificity of which we first confirmed (Supplementary Fig. S1A). Here, ERCC6L is linked to breast cancer.